Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus haloperidol for acute agitation in the emergency department
IRCT20230612058465N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in agitation (acute) comparing Ketamine with Haloperidol (2 arms). Primary endpoints: Side effects comparison, Time to sedation and 1 more. Started Jun 2023; status: completed.
02
Drugs
ketaminehaloperidol
03
Conditions
agitation (acute)
Beyond the preview
Go deeper on IRCT20230612058465N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230612058465N1.